Kane Biotech Announces Attendance at Upcoming Wound Care Conferences

GlobeNewswireSep 26 08:30 ET

Kane Biotech Brief: Company Realizes $10.4 Million Gain on the Sale of STEM

MT NewswiresAug 29 16:17 ET

Kane Biotech Brief: Net Income for Q2 2024 Was $9,201,830 Compared to a Net Loss of ($967,905) for the Quarter Ended June 30, 2023

MT NewswiresAug 29 16:16 ET

Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 – Conference Call to Follow

GlobeNewswireAug 22 16:30 ET

Kane Biotech Announces Distribution Agreement With Razan Medical Trading for Revyve Antimicrobial Wound Gel

GlobeNewswireAug 22 08:30 ET

Kane Biotech Receives Funding Support to Expand the Revyve Antimicrobial Wound Gel Family

GlobeNewswireAug 13 08:30 ET